Researchers have been excited about the medication , a groundbreaking dual compound showing promising results in early trials for body management. It acts by targeting both systems: GLP-1 and GIP, that , when activated , support regulate appetite and improve calorie burn. Initial findings suggest substantial weight reduction and possible improvemen